Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2265 (LINC02265)

Target: LINC02265
Molecular classification: Long non-coding RNA, Long intergenic non-coding RNA

Overview

Long intergenic non-protein coding RNA 2265 (LINC02265) is a human long non-coding RNA (lncRNA) classified as a long intergenic non-coding RNA (lincRNA) based on its location in the genome outside annotated protein-coding regions[3]. There is no published evidence directly linking LINC02265 to disease, cellular pathways, or molecular targets as of September 2025. While lincRNAs as a class are known to participate in gene regulation, epigenetic modification, and various cellular processes[1], the specific functions, disease associations, or therapeutic relevance of LINC02265 have not been characterized in the scientific literature[3].

Other names: LINC02265

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2265 (LINC02265).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2265 (LINC02265).

Explore the full profile